Showing results (1161-1170 of 1,195) with videos related to
Sort By:
Pageof 120
Pharmaceutical Statistics|February 14, 2024
Introduction to qualification and validation of an immunoassaySarah JanssenPharmaceutical Statistics|November 16, 2023
Statistical analysis of actigraphy data with generalised additive modelsEdoardo Lisi, Juan J AbellanPharmaceutical Statistics|October 14, 2023
Effects of duration of follow-up and lag in data collection on the performance of adaptive clinical trialsAnders Granholm, Theis Lange, Michael O Harhay, et al.Pharmaceutical Statistics|July 21, 2023
Adherence, per-protocol effects, and the estimands frameworkOliver KeenePharmaceutical Statistics|July 11, 2023
Leading beyond regulatory approval: Opportunities for statisticians to optimize evidence generation and impact clinical practiceJenny Devenport, Alexander Schacht, Pharmaceutical Statistics|August 9, 2023
Adaptive designs for IVPT data with mixed scaled average bioequivalenceDaeyoung Lim, Elena Rantou, Jessica Kim, et al.Pharmaceutical Statistics|August 26, 2023
Simulating and reporting frequentist operating characteristics of clinical trials that borrow external information: Towards a fair comparison in case of one-arm and hybrid control two-arm trialsAnnette Kopp-Schneider, Manuel Wiesenfarth, Leonhard Held, et al.Pharmaceutical Statistics|June 15, 2023
Alone, together: On the benefits of Bayesian borrowing in a meta-analytic settingOfir Harari, Mohsen Soltanifar, Andre Verhoek, et al.Pharmaceutical Statistics|May 31, 2023
Variance estimation of the risk difference when using propensity-score matching and weighting with time-to-event outcomesGuy Cafri, Peter C AustinPharmaceutical Statistics|October 3, 2023
Duration of and time to response in oncology clinical trials from the perspective of the estimand frameworkHans-Jochen Weber, Stephen Corson, Jiang Li, et al.Pageof 120